Clinical Trial Update: A Safety and Efficacy Study of One-time SAR402663 in Adults With Neovascular Age-related Macular Degeneration [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial update for a one-time investigational drug SAR402663 in adults with neovascular age-related macular degeneration; the study is in Phase 1/Phase…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neovascular Age-related Macular Degeneration

Drugs mentioned

• SAR402663

Snippet

Sponsor: Sanofi | Conditions: Neovascular Age-related Macular Degeneration | Phase 1, Phase 2 | Status: RECRUITING